Global Immunofluorescence Assay Market To Grow At A CAGR Of 6.2% By 2030

The global immunofluorescence assay market size was worth around USD 2.6 billion in 2021 and is predicted to grow to around USD 4.5 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.2% between 2022 and 2030.

Immunofluorescence Assay is a method used in the antigen-antibody response. The fluorescent dye that is used to tag or label the antibodies in the assay enables them to bind with the corresponding antigen. In a fluorescent microscope, flow cytometer, automated imaging device, or array scanner, the antigen-antibody complex is further seen. The method is employed for researching particular proteins in cell cultures, body fluid samples from patients, and others. In terms of immunofluorescence assays, direct and indirect immunofluorescence are the two main categories. An imaging device, assay kit, antigen-specific antibodies, and reagent are needed for the assay.

One of the major factors driving the global immunofluorescence assay market is the growing prevalence of chronic diseases across the globe. The surging research and development activities to innovate new ways of testing are boosting the growth of the immunofluorescence assay market. Moreover, the increasing burden of diseases like neurological disorders, infectious diseases, cancer, diabetes, cardiovascular diseases, autoimmune diseases, and many others globally has positively shaped the trajectory of the global market during the forecast period.

The growing investments by the major market players in innovating more safer and effective tests kit are bolstering the growth of the immunofluorescence assay market. The extensive research to enhance the quality of test kits and protocols to strengthen the global market is supporting the growth of the global market.

The global immunofluorescence assay market is segmented based on product, type, disease, end-use industry, and region.

The global market is divided into reagents, kits, antibodies, instruments, and consumables & accessories based on the product. In 2021, the kits segment had the biggest revenue share, and it is anticipated that it will continue to dominate during the projected period. Rising demand for calibrated reagents and solutions from academic institutions, contract research organizations (CROs), and research organizations is responsible for the segment's expansion. Increasing the creation of comprehensive solutions, clinical diagnostic and research applications for immunofluorescence tests are anticipated to develop, which will boost demand for assay kits and sustain future revenue growth for this market.

The immunofluorescence market is divided into pharmaceutical and biotechnology companies, academic and research institutes, CROs, and hospital and diagnostic centers based on the end-use industry. Throughout the projected period, pharmaceutical and biotechnology firms are anticipated to occupy the majority of the market share.

The rising use of immunofluorescence assays in drug research and development procedures to investigate the etiology of diseases, the expansion of laboratory automation technologies, and technological advancements in immunofluorescence assays are all credited with the segment's rise. In addition, the growing demand for fluorescence microscopy and subsequent use of immunofluorescence samples in biotechnology and biopharmaceutical research is expected to drive revenue growth of this segment over the forecast period.

North America accounts for the largest share of the global immunofluorescence assay market due to the rising incidences of infectious and chronic illness cases. Moreover, the growing research and development activities coupled with the increasing investments further support the growth of the regional market. Moreover, Europe is expected to witness significant growth with a high CAGR during the forecast period due to the growing need for improved products for healthcare and academic purposes. Furthermore, Asia Pacific is also growing fast in the global market due to the emergence of prominent market players in the region.

The global immunofluorescence assay market is dominated by players like Danaher, Sino Biological Inc., Enzo Life Sciences, Inc., Agilent Technologies, Inc., BD, Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam plc., Thermo Fisher Scientific Inc., MaxVision Biosciences Inc, AESKU GROUP GmbH, Elabscience, Inc., EpiGentek Group, Abnova Corporation, J. Mitra & Co. Pvt. Ltd., Celebs, Zyagen, Inc., Bruker Corporation among others.

Recent Development:

• In July 2020, Ultivue, Inc. and OracleBio formed a collaborative partnership to accelerate personalized tumor characterization for drug research and development in translational and clinical oncology with the application of multiplex immunofluorescence staining and imaging.
• In September 2022, Propath UK and Nucleai collaborated to develop and validate a 30-plex immunofluorescence panel focused on protein targets relevant to immuno-oncology.

This review is based on a report by Zion Market Research, titled “Immunofluorescence Assay Market By Product (Reagents, Kits, Antibodies, Instruments, and Consumables & Accessories), By Type (Direct Immunofluorescence and Indirect Immunofluorescence), By Disease (Cancer, Cardiovascular Disease, Autoimmune Disease, Infectious Disease, and Others), By End-use Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs and Hospital & Diagnostic Centers) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2030.”- Report at https://www.zionmarketresearch.com/report/immunofluorescence-assay-market

The global immunofluorescence assay market is segmented as follows:

By Product

• Reagents
• Kits
• Antibodies
• Instruments
• Consumables & Accessories

By Type

• Direct Immunofluorescence
• Indirect Immunofluorescence

By Disease

• Cancer
• Cardiovascular Disease
• Autoimmune Disease
• Infectious Disease
• Others

By End-use Industry

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• CROs
• Hospital & Diagnostic Centers

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com